Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The price of Fate Therapeutics Inc (NASDAQ: FATE) closed at $0.94 in the last session, up 1.70% from day before closing price of $0.92. In other words, the price has increased by $1.70 from its previous closing price. On the day, 1.0 million shares were traded. FATE stock price reached its highest trading level at $0.9584 during the session, while it also had its lowest trading level at $0.8624.
Ratios:
We take a closer look at FATE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.58 and its Current Ratio is at 7.58. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.24.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 06 ’25 when Wolchko J Scott bought 113,178 shares for $0.93 per share.
Bressi Jerome Charles sold 5,980 shares of FATE for $9,269 on Jan 10 ’25. The insider now owns 270,203 shares after completing the transaction at $1.55 per share. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the insider of the company, sold 5,654 shares for $1.55 each. As a result, the insider received 8,764 and left with 336,707 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 107171112 and an Enterprise Value of -107519600. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.86 while its Price-to-Book (P/B) ratio in mrq is 0.33. Its current Enterprise Value per Revenue stands at -7.888 whereas that against EBITDA is 0.609.
Stock Price History:
The Beta on a monthly basis for FATE is 2.34, which has changed by -0.8370884 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $6.48, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is -13.59%, while the 200-Day Moving Average is calculated to be -62.89%.
Shares Statistics:
According to the various share statistics, FATE traded on average about 2.35M shares per day over the past 3-months and 2497480 shares per day over the past 10 days. A total of 113.93M shares are outstanding, with a floating share count of 103.49M. Insiders hold about 9.70% of the company’s shares, while institutions hold 84.91% stake in the company. Shares short for FATE as of 1741910400 were 14571003 with a Short Ratio of 6.97, compared to 1739491200 on 13060901. Therefore, it implies a Short% of Shares Outstanding of 14571003 and a Short% of Float of 14.580000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
